Asia Pacific Expansion and Innovation for Biopharmas: Commercial, Funding and Scouting Models

12:00 PM - 1:00 PM (EDT), Monday, June 5, 2023 ・ Session Room 205ABC
Asia Pacific is home to 60% of the world population, 35% of the global GDP and 5 out of the top 15 pharmaceutical markets. It is also increasingly a source of innovation, whether from academia in Japan or start up biotechs in China. Join us in this discussion on the cross-border opportunities with the Asia Pacific market for international biopharmas, and how
Sponsored By
Global Sector Co-Head, Healthcare and Life Sciences and Greater China Managing Partner
LEK Consulting
Panacea Venture
President & CEO
Genexine, Inc.
Executive Director for Business Development and Licensing